FDA Drug Regulator Tracy Beth Høeg Departs Amid Leadership Turmoil

Dr. Tracy Beth Høeg, the head of the FDA's drug division, is leaving her post following the resignation of the agency commissioner. Sources indicate she is departing after declining to resign herself, signaling deep instability within the federal health agency. This leadership shakeup raises concerns about regulatory continuity and the safety of approved medications during a period of political transition.